Sphera Funds Management’s vTv Therapeutics VTVT Stock Holding History

Sphera Funds Management’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,042	Closed	-$1.15M	–	125
2018 Q1	$1.15M	Hold	7,042	–	–	0.17%	82
2017 Q4	$1.69M	Sell	7,042 -458	-6%	-$103K	0.2%	105
2017 Q3	$1.79M	Hold	7,500	–	–	0.26%	89
2017 Q2	$1.49M	Hold	7,500	–	–	0.25%	97
2017 Q1	$1.97M	Buy	7,500 +2,500	+50%	+$570K	0.38%	72
2016 Q4	$966K	Hold	5,000	–	–	0.24%	84
2016 Q3	$1.44M	Buy	+5,000	New	+$1.2M	0.23%	87

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Sphera Funds Management's VTVT Position: Q2 2018 in Review

Sphera Funds Management sold out of vTv Therapeutics (VTVT) in Q2 2018, closing a stake of 7,042 shares — an estimated $1.15M sold.

Sphera Funds Management first reported a position in VTVT in Q3 2016 and held it in 7 quarters. The position peaked at $1.97M in Q1 2017. 27 funds tracked by Wall St. Rank hold VTVT as of Q2 2018.

Sphera Funds Management reported no remaining vTv Therapeutics position as of Q2 2018 after selling out during the quarter.
Sphera Funds Management sold 7,042 vTv Therapeutics shares in Q2 2018, an estimated $1.15M.
Sphera Funds Management first reported a position in vTv Therapeutics in Q3 2016 and held it in 7 quarters.
Sphera Funds Management's vTv Therapeutics position peaked at $1.97M in Q1 2017.
27 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.